Structural requirement of tunicamycin V for MraY inhibition

Bioorg Med Chem. 2019 Apr 15;27(8):1714-1719. doi: 10.1016/j.bmc.2019.02.035. Epub 2019 Mar 2.

Abstract

Elucidating a structure-activity relationship study by evaluating a series of truncated analogues is a simple but important and effective tactic in medicinal chemistry based on natural products with a large and complex chemical structure. In this study, a series of truncated analogues of tunicamycin V were designed and synthesized and their MraY inhibitory activity was investigated in order to gain insight into the effect of these moieties on MraY inhibition.

Keywords: Antibacterial; Enzyme inhibitor; Natural products; Nucleoside; Structure-activity relationship.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / metabolism
  • Bacterial Proteins / antagonists & inhibitors*
  • Bacterial Proteins / metabolism
  • Biological Products / chemistry
  • Biological Products / metabolism
  • Drug Design
  • Inhibitory Concentration 50
  • Staphylococcus aureus / enzymology
  • Transferases (Other Substituted Phosphate Groups)
  • Transferases / antagonists & inhibitors*
  • Transferases / metabolism
  • Tunicamycin / chemistry*
  • Tunicamycin / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Biological Products
  • Tunicamycin
  • Transferases
  • Transferases (Other Substituted Phosphate Groups)
  • mraY protein, Bacteria